Note 9 Stockholders' Equity

3 Months Ended

Dec. 31, 2022

Stockholders' Equity Note [Abstract]

Stockholders' Equity Note Disclosure [Text Block]

Stockholders’ Equity

Accumulated Other Comprehensive Income

Accumulated other comprehensive income, net of tax as applicable, consisted of the following:

	As of
	December 31, 2022		October 1, 2022
	(In thousands)
Foreign currency translation adjustments	$	70,112	$	63,929
Unrealized holding gains (losses) on derivative financial instruments	5,285		4,112
Unrecognized net actuarial losses and transition costs for benefit plans	(12,122)		(11,716)
Total	$	63,275	$	56,325

Stock Repurchase Program

During the three months ended December 31, 2022 and January 1, 2022, the Company repurchased 4 thousand and 1.5 million shares of its common stock for $0.2 million and $60 million, respectively, under stock repurchase programs authorized by the Board of Directors. These programs have no expiration dates and the timing of repurchases will depend upon capital needs to support the growth of the Company’s business, market conditions and other factors. Although stock repurchases are

intended to increase stockholder value, they also reduce the Company’s liquidity. As of December 31, 2022, an aggregate of $164 million remains available under these programs.

In addition to the repurchases discussed above, the Company withheld 0.1 million and 0.2 million shares of its common stock during the three months ended December 31, 2022 and January 1, 2022, respectively, in settlement of employee tax withholding obligations due upon the vesting of restricted stock units. The Company paid $8 million and $9 million for the three months ended December 31, 2022 and January 1, 2022, respectively, to applicable tax authorities in connection with these repurchases.